Filter
200
Filtered Results: 200
Text search:
buruli
ulcer
Featured
Recommendations
16
New Publications
46
Language
Document type
No document type
72
Studies & Reports
48
Guidelines
25
Strategic & Response Plan
13
Manuals
11
Videos
7
Resource Platforms
6
Fact sheets
6
Brochures
5
Training Material
3
Infographics
3
Online Courses
1
Countries / Regions
Global
25
Benin
11
Ghana
7
Liberia
6
Togo
5
Nigeria
4
Congo, Democratic Republic of
4
Sierra Leone
2
Cameroon
2
Syria
2
Iran
2
Africa
2
Jordan
2
Germany
2
Saudi Arabia
2
Western and Central Europe
2
Lebanon
2
Sudan
2
Iraq
2
Pakistan
2
Kenya
1
Albania
1
Burkina Faso
1
Afghanistan
1
Malawi
1
Morocco
1
Qatar
1
Middle East and North Africa
1
Tunisia
1
Uganda
1
Djibouti
1
Egypt
1
Yemen
1
Greece
1
Palestine
1
Georgia
1
Libya
1
Somalia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Buruli Ulcer
24
Policies
18
Studies & Reports
12
NTDs & Others
10
Dermatology
7
Statistics
7
Public Health
4
Bacteriology
4
Guidelines
4
Leprosy
4
Disease Prevention & Control
4
Drugs & Medical Equipment
3
Other
3
Primary Health Care
3
Leishmaniasis
3
Communicable Diseases
2
Helminthiasis
2
Yaws
2
Community Health
2
Countries
2
Policies & Guidelines HIV & TB
2
Community Health
2
Capacity Building
2
WASH
2
Surgery & Anaesthesia
2
Communicable Diseases
2
Health Systems
2
Non-communicable Diseases
2
TB
2
Pharmacy & Technology
1
Child Health
1
Trachoma
1
Online Courses & Platforms
1
Taeniasis/ Cysticercosis
1
Onchocerciasis
1
Schistosomiasis
1
Lymphaticfilariasis
1
x MEDBOX Issue Brief & Annual Reports x
1
Neglected Tropcial Diseases NTDs
1
Public Health
1
Health System Strengthening
1
Chagas
1
Clinical Guidelines
1
Yellow Fever
1
Demograhic Health Surveys DHS
1
Information, Education and Communication (IEC)
1
Disabilities
1
General Guidelines
1
Parasitology
1
Laboratory Technologies
1
HIV & STI
1
Physiotherapy & Rehabilitation
1
Toolboxes
Information & Education Material (IEC)
25
Clinical Aspects & Diagnostics
24
Studies & Reports
16
Capacity Building & Resources
13
Disability Prevention & Rehabilitation
10
Overview, Studies & Reports
9
Community Health Workers CHW
8
Statistics & Facts
8
Surveillance
5
Others
5
Studies & Reports
4
NTDs General
4
Prevention of Disabilites
4
Policies & Strategies
3
Strategies & Roadmaps
3
Capacity Building & Resource platforms
3
Yaws & other Endemic Treponematoses
3
Nigeria
3
One Health
2
Buruli Ulcer
2
Mycetoma, Chromoblastomycosis & other deep mycosis
2
Onchocerciasis
2
Snakebite envenoming
2
Diagnosis
2
Germany
2
Local Action
1
Clinical Guidelines
1
Vaccines & Immunization
1
Yellow Fever
1
Prevention & Control
1
Surgery & Rehabilitation
1
Adults
1
Introduction to Global Health
1
WASH
1
National Policies
1
Concepts of Global Health
1
Curricula & Core Competencies
1
Prevention & Control
1
Physiotherapy & Rehabilitation
1
Studies
1
Hospital Readiness/Essential Health Services
1
RCCE Guides & Manuals
1
At Home
1
Ecuador
1
Rational use of Medicine
1
HIV &TB
1
Zoonoses
1
NTDs
1
Leishmaniasis
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
Vector control
1
General Information & Methodology
1
Community Based Rehabilitation (CBR)
1
General
1
Ghana
1
Assistive devices & technologies
1
Community Worker
1
Disease Prevention & Control
1
Training
1
Research & Access
1
TB/HIV Coinfection
1
TB
1
Universal Health Coverage & Primary Health Care
1
Public Health
1
Treatment & Clinical Management
1
A guide for field health workers
Buruli Ulcer Prevention of Disability (POD)
recommended
This manual is for use by doctors, nurses, rehabilitation specialists, National Buruli ulcer Control Programme managers and other health workers involved in the prevention of disability activities in Buruli ulcer.
Technical Update
Areas of Africa endemic for Buruli ulcer (BU), caused by Mycobacterium ulcerans, also have a high prevalence of human immunodeficiency virus (HIV), with adult prevalence rates between 1% and 5% (Maps). However, there is limited information on the prevalence of BU–HIV coinfection....
Buruli ulcer mostly affects children. This comic is aimed at giving them a better knowledge of the disease.
A total of 18 laboratories from 13 countries participated in the four rounds of EQA: 10 laboratories from eight African endemic countries, four of which participated in all four rounds and three in three rounds. The overall results showed that the median performance of these laboratories improved ov...
This course is intended to provide basic information for front-line health workers to be able to implement the recommended control measures to minimize the negative impact of Buruli ulcer on populations.
In 2013, WHO and the Foundation for Innovative New Diagnostics convened a meeting of Buruli ulcer experts in Geneva, Switzerland (9) at which two priority unmet needs in diagnosis were identified:
a diagnostic test for early detection of Buruli ulcer in symptomatic patients with sufficient positive...
The Lancet olume 395, ISSUE 10232, P1259-1267, April 18, 2020. Buruli ulcer is a neglected tropical disease caused by Mycobacterium ulcerans infection that damages the skin and subcutis. It is most prevalent in western and central Africa and Australia. Standard antimicrobial treatment with oral rifa...
Phillips and colleagues have shown that rifampicin combined with clarithromycin is non-inferior to RS8, and is safer. This much anticipated trial provides us with a high degree of confidence that an 8-week course of oral rifampicin and clarithromycin should now be the cornerstone of the treatment of...
The Lancet Global Health Volume 7, ISSUE 7, e912-e922, July 01, 2019
Buruli ulcer is caused by infection with Mycobacterium ulcerans. The disease is reported in more than 33 countries worldwide, but only about half of these countries regularly report data to WHO; most cases are reported from subregions of West and Central Africa. The mode of transmission is not known...
Current Tropical Medicine Reports (2018) 5:247–256 https://doi.org/10.1007/s40475-018-0166-2 .Purpose of the Review Buruli ulcer (BU) is a necrotizing and disabling cutaneous disease caused by Mycobacterium ulcerans, one of the skin-related neglected tropical diseases (skin NTDs). This article aim...
PLoS Negl Trop Dis 5(6): e1187. doi:10.1371/journal.pntd.0001187. Buruli ulcer (BU), caused by Mycobacterium ulcerans infection, is a debilitating disease of the skin and underlying tissue which starts as a painless nodule, oedema or plaque and could develop into painful and massive ulcers if left u...
A major objective of this open access book is to summarize the current status of Buruli Ulcer (BU) research for the first time. It will identify gaps in our knowledge, stimulate research and support control of the disease by providing insight into approaches for surveillance, diagnosis, and treatmen...
The World Health Organization (WHO) convened a meeting of the Technical Advisory Group on Buruli ulcer at its headquarters in Geneva, Switzerland on 25 to 27 March 2019
The meeting was held from 26 to 27 March 2018 to review and discuss the following topics:
Advances and challenges in the use of fTLC, and new approaches to detecting mycolactone using monoclonal antibodies (mAbs).
The status of development of rapid diagnostic tests (RDTs) targeting the M...
Volume 2016 | Article ID 5310718 | https://doi.org/10.1155/2016/5310718. Buruli ulcer (BU) is a necrotizing cutaneous infection caused by Mycobacterium ulcerans. Early diagnosis is crucial to prevent morbid effects and misuse of drugs. We review developments in laboratory diagnosis of BU, discuss li...
